First Commonwealth Financial Corp PA lessened its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 8.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,892 shares of the medical research company’s stock after selling 610 shares during the period. Thermo Fisher Scientific comprises 1.4% of First Commonwealth Financial Corp PA’s holdings, making the stock its 18th largest holding. First Commonwealth Financial Corp PA’s holdings in Thermo Fisher Scientific were worth $1,309,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. Longview Partners Guernsey LTD grew its position in shares of Thermo Fisher Scientific by 6.8% during the 4th quarter. Longview Partners Guernsey LTD now owns 4,876,890 shares of the medical research company’s stock worth $926,024,000 after purchasing an additional 311,977 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Thermo Fisher Scientific by 4.2% during the 4th quarter. Geode Capital Management LLC now owns 3,917,221 shares of the medical research company’s stock worth $742,108,000 after acquiring an additional 158,961 shares in the last quarter. Veritas Asset Management LLP boosted its position in shares of Thermo Fisher Scientific by 44.1% during the 3rd quarter. Veritas Asset Management LLP now owns 3,503,259 shares of the medical research company’s stock worth $662,817,000 after acquiring an additional 1,072,500 shares in the last quarter. Wells Fargo & Company MN boosted its position in shares of Thermo Fisher Scientific by 2.8% during the 4th quarter. Wells Fargo & Company MN now owns 3,189,088 shares of the medical research company’s stock worth $605,543,000 after acquiring an additional 85,751 shares in the last quarter. Finally, Clearbridge Investments LLC boosted its position in shares of Thermo Fisher Scientific by 5.3% during the 4th quarter. Clearbridge Investments LLC now owns 2,862,399 shares of the medical research company’s stock worth $543,512,000 after acquiring an additional 143,518 shares in the last quarter. Hedge funds and other institutional investors own 87.63% of the company’s stock.

How to Become a New Pot Stock Millionaire

Several analysts recently issued reports on the stock. Leerink Swann reiterated an “outperform” rating and set a $200.00 price target (down previously from $216.00) on shares of Thermo Fisher Scientific in a research report on Monday, December 4th. Morgan Stanley increased their price target on shares of Thermo Fisher Scientific from $223.00 to $227.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. BTIG Research assumed coverage on shares of Thermo Fisher Scientific in a research report on Friday, January 5th. They set a “buy” rating and a $230.00 price target on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a research report on Saturday, January 20th. Finally, Barclays increased their price target on shares of Thermo Fisher Scientific from $225.00 to $245.00 and gave the stock an “overweight” rating in a research report on Thursday, February 1st. Two investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and an average target price of $220.50.

In other Thermo Fisher Scientific news, insider Patrick M. Durbin sold 6,000 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $217.55, for a total value of $1,305,300.00. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Gregory J. Herrema sold 33,327 shares of the firm’s stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $219.70, for a total transaction of $7,321,941.90. Following the transaction, the senior vice president now directly owns 60,471 shares of the company’s stock, valued at approximately $13,285,478.70. The disclosure for this sale can be found here. Insiders sold 48,827 shares of company stock worth $10,606,272 in the last 90 days. Company insiders own 0.49% of the company’s stock.

Shares of TMO stock opened at $214.72 on Wednesday. Thermo Fisher Scientific Inc. has a 52-week low of $151.74 and a 52-week high of $226.44. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.34 and a quick ratio of 0.92. The firm has a market cap of $84,551.45, a P/E ratio of 38.34, a price-to-earnings-growth ratio of 1.54 and a beta of 1.15.

Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Wednesday, January 31st. The medical research company reported $2.79 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.13. Thermo Fisher Scientific had a net margin of 10.64% and a return on equity of 16.01%. The firm had revenue of $6.05 billion for the quarter, compared to analyst estimates of $5.72 billion. During the same quarter last year, the business posted $2.41 earnings per share. The company’s quarterly revenue was up 22.1% on a year-over-year basis. equities research analysts expect that Thermo Fisher Scientific Inc. will post 10.81 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, April 16th. Shareholders of record on Thursday, March 15th will be given a $0.17 dividend. The ex-dividend date is Wednesday, March 14th. This represents a $0.68 dividend on an annualized basis and a yield of 0.32%. This is a positive change from Thermo Fisher Scientific’s previous quarterly dividend of $0.15. Thermo Fisher Scientific’s dividend payout ratio (DPR) is currently 12.14%.

TRADEMARK VIOLATION WARNING: “First Commonwealth Financial Corp PA Has $1.31 Million Holdings in Thermo Fisher Scientific Inc. (TMO)” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.watchlistnews.com/first-commonwealth-financial-corp-pa-has-1-31-million-holdings-in-thermo-fisher-scientific-inc-tmo/1952172.html.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.